Quarterly Results
ABOS
FY2025Q3
07:00:00
Pre-Market
Revenue
$0.00
-
EPS
-$0.44
+30.16%
Al Prediction
-AI Summary
Report
Attend WebcastABOS
FY2025Q2
07:00:00
Pre-Market
Revenue
$0.00
-
EPS
-$0.68
-25.93%
Al Prediction
-AI Summary
ReportAttend WebcastABOS
FY2025Q1
07:00:00
Pre-Market
Revenue
$0.00
-
EPS
-$0.48
+14.29%
Al Prediction
-AI Summary
Attend WebcastABOS Earnings Forecast
1Y
3Y
5Y
Currency: USD
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price0
Stock Price
Go Down
-2.93%
In Past 3 Month
Earnings Forecast
Revenue
EPS
Currency:
No data
Actual
Estimate
Al Analysis
Earnings Surprise Analysis
Revenue
EPS
1Y
3Y
Al Analysis
Earnings Reaction
The chart below shows how ABOS performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ABOS sees a +1.63% change in stock price 10 days leading up to the earnings, and a -2.67% change 10 days following the report. On the earnings day itself, the stock moves by +2.50%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed -7.18% on the day following the earnings release and then changed by 0.00% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
People Also Watch
Frequently Asked Questions
What were the key highlights of ABOS's latest earnings report for FY2025Q3?
ABOS reported its FY2025Q3 earnings on 2025-11-12, showcasing a revenue of 0.00 against an estimate of 0.00, resulting in a 0% surprise. The EPS was -0.44, surpassing the expected -0.63 by 30.16% . The stock experienced a -1.02% price change on the earnings day and a -19.8% change over the next five days, reflecting market reactions to the results.
How did ABOS's stock price react after the FY2025Q3 earnings release?
Following ABOS's FY2025Q3 earnings announcement on 2025-11-12, the stock price moved by -1.02% on the day of the release. Over the subsequent five days, it saw a -19.80% change. Historically, ABOS's stock price tends to shift by an average of +1.63% in the 10 days leading up to earnings and -2.67% in the 10 days following, providing insight into potential market.
What are the revenue and EPS estimates for ABOS for undefined?
For , analysts estimate ABOS’s annual revenue to reach undefined, while the EPS is projected at -0.43. These estimates reflect recent revisions, with revenue estimates revised Revenue Go Down by -2.93% and EPS estimates No Change by % over the past three months, indicating analyst expectation in the company’s performance.
How does ABOS's stock price correlate with earnings forecast revisions?
The correlation between ABOS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for were Go Down by -2.93%, while EPS estimates moved No Change by % . This trend suggests that price dips could present buying opportunities for investors.
What should investors expect from ABOS's next earnings report?
Based on historical trends, ABOS's stock price typically moves by +1.63% in the 10 days before its earnings and -2.67% in the 10 days after. For the upcoming earnings, analysts expect an EPS of -0.43 and revenue of undefined.
What is the sentiment in Acumen Pharmaceuticals Inc (ABOS) Q3 2025 Earnings Call Summary?
The company's financial health shows a net loss and a reliance on existing cash reserves, which is concerning. However, there is optimism in their strategic collaboration with JCR and ongoing trials, which could potentially lead to positive outcomes. The Q&A reveals cautious optimism and strategic planning, but also highlights uncertainties in clinical trial outcomes and financial sustainability. The lack of guidance and potential financial risks balance out the positive aspects, resulting in a neutral sentiment.